Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCH-759 in Chronic Hepatitis C
NCT00389298Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vch-759 in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Oct 2006; status: completed.
02
Drugs
vch-759
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00389298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389298.